A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care



Status:Enrolling by invitation
Conditions:Arthritis, Arthritis, Chronic Pain, Chronic Pain, Chronic Pain, Peripheral Vascular Disease, Psychiatric, Psychiatric, Diabetes
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology, Musculoskeletal, Psychiatry / Psychology, Rheumatology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:September 2014
End Date:December 2016

Use our guide to learn which trials are right for you!

Randomized, Blinded, Controlled Trial to EValuate the EcOnomic and ClinicaL Outcomes of Utilizing Genetic Testing to Improve Therapeutic Decision-Making COmpared to Empiric Prescribing as the StaNdard of Care

The purpose of this study is to evaluate the impact of genetic testing on healthcare
decisions and patient outcomes for patients suffering from pain, cardiovascular problems,
Arthritis, Type II Diabetes, and/or Mental Health disorders. Results of genetic testing will
also be compared with the clinical outcome measures collected to discover novel genetic
factors that may influence patient care.

The molecular basis of many pharmacogenetic polymorphisms has now been elucidated, with
genetic variations resulting in alteration of expression or function of receptors, enzymes,
and transporters relevant to the safety and efficacy of a medical treatment. Genetics has
been shown to be a significant factor in the variability of responses of medication choices
and doses. With the rapid development of cost-effective high throughput molecular genotyping
methods, pharmacogenetics has become increasingly important because of its potential to
identify patients with increased risk of adverse drug reactions or decreased likelihood of
response at standard dosage of drug. By identifying the genetic risks and the most effective
therapy for an individual patient, clinicians may improve the efficacy of treatment and
decrease the risk of adverse drug events. The addition of pharmacogenetic testing to routine
clinical practice may also be extremely helpful because of the cost reduction associated
with the identification of patients that will not respond to expensive drugs or with the
identification of patients likely to suffer from severe adverse events. There are also
tremendous efforts in the pharmaceutical industry to lower the cost for drug development;
pharmacogenetics may fulfill the need to provide the right drug to the right patient and to
increase the likelihood of success of large phase II and phase III clinical trials.

The purpose of this study is to evaluate how currently available genetic tests are being
implemented in various clinics around the United States, and whether this information
results in benefits to patient care. Patients presenting to clinics with pain,
cardiovascular conditions, Arthritis, Type II Diabetes, and/or Mental Health disorders that
are receiving Proove Bioscience's genetic testing will complete validated questionnaires to
measure specific outcomes related to their treatment at each clinical visit, including
medication efficacy, reduction in adverse drug events, and healthcare utilization.
Physicians will document any changes made to treatment regimens, including adjustments to
medications or non-pharmacological treatments, and any improvements in the outcome measures.
Statistical analysis will be performed to calculate relationships between genotypic and
phenotypic data points collected in this study.

The results of this study will provide a measurable understanding of the medical and
economic value of implementing genetic testing into clinical care. Furthermore, data points
collected will be used to examine novel correlations and associations between single
nucleotide polymorphisms and longitudinal clinical outcome measures.

Inclusion Criteria:

- Provide signed and dated informed consent form

- Willing to comply with all study procedures and be available for the duration of the
study

- Male or Female, at least 18 years of age

- Currently taking or a candidate for medication

- Documented or recent complaint within 90 days with initial date of onset

Exclusion Criteria:

- Severe hepatic or renal disease (where current pharmaceutical dosing is affected
and/or requires adjustment of standard dosing prior to PGx testing)

- Significant diminished mental capacity that is unable to understand the protocol,
surveys and questionnaires; unable to read/write English or Spanish.

- Recent febrile illness that precludes or delays participation by more than 1 month

- Pregnancy or lactation

- Participation in a clinical study that may interfere with participation in this study

- Anything that would place the individual at increased risk or preclude the
individual's full compliance with or completion of the study.
We found this trial at
31
sites
Littleton, Massachusetts 01460
?
mi
from
Littleton, MA
Click here to add this to my saved trials
Altoona, Pennsylvania 16601
?
mi
from
Altoona, PA
Click here to add this to my saved trials
Baltimore, Maryland 21224
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Beverly Hills, California 90212
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Beverly Hills, California 90212
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Boca Raton, Florida 33428
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Chattanooga, Tennessee 37416
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Davie, Florida 33328
?
mi
from
Davie, FL
Click here to add this to my saved trials
Fort Lauderdale, Florida 33316
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Fort Lauderdale, Florida 33316
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Fort Lauderdale, Florida 33334
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Fort Wayne, Indiana 46825
?
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Fresno, California 93710
?
mi
from
Fresno, CA
Click here to add this to my saved trials
Fresno, California 93726
?
mi
from
Fresno, CA
Click here to add this to my saved trials
Greer, South Carolina 29651
?
mi
from
Greer, SC
Click here to add this to my saved trials
Hixson, Tennessee 37343
?
mi
from
Hixson, TN
Click here to add this to my saved trials
La Jolla, California 92037
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
Los Angeles, California 90017
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Louisville, Kentucky 40214
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Macon, Georgia 31210
?
mi
from
Macon, GA
Click here to add this to my saved trials
Morristown, Tennessee 37813
?
mi
from
Morristown, TN
Click here to add this to my saved trials
Murrieta, California 92563
?
mi
from
Murrieta, CA
Click here to add this to my saved trials
Portland, Oregon 97216
?
mi
from
Portland, OR
Click here to add this to my saved trials
Rolling Hills, California 90274
?
mi
from
Rolling Hills, CA
Click here to add this to my saved trials
San Diego, California 92122
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Sandpoint, Idaho 83864
?
mi
from
Sandpoint, ID
Click here to add this to my saved trials
Spokane, Washington 99006
?
mi
from
Spokane, WA
Click here to add this to my saved trials
Torrance, California 90501
?
mi
from
Torrance, CA
Click here to add this to my saved trials
Vandalia, Ohio 45414
?
mi
from
Vandalia, OH
Click here to add this to my saved trials
Vista, California 92083
?
mi
from
Vista, CA
Click here to add this to my saved trials